Topic Abbott

Companies Abbott

News Abbott

• Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury

  Abbott and Action Pharma A/S announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.AP214 is in development to prevent acute kidney injury (AKI) associated with major cardiac surgery in patients at increased risk and has further potential in adjacent more

• Abbott Announces Collaboration with Syngene to Open Nutrition R&D Center

  Abbott announced plans to establish its first nutrition research and development center in the country in collaboration with Syngene. The Abbott Nutrition R&D Center in India will focus on the development of science-based, affordable nutrition products for the country and enable the expansion of Abb more

• Abbott's HUMIRA Approved in Europe for Treatment of Ulcerative Colitis

  Abbott announced that the European Commission has approved HUMIRA®(adalimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients who have had an inadequate response to conventional therapy. With this approval, HUMIRA becomes the first and only self-injectab more

Publications Abbott

• N-Player Quantum Games in an EPR Setting

  by James M. Chappell, Azhar Iqbal, Derek Abbott The -player quantum games are analyzed that use an Einstein-Podolsky-Rosen (EPR) experiment, as the underlying physical setup. In this setup, a player’s strategies are not unitary transformations as in alternate quantum game-theoretic framew more

• Radiation risks: Raiders of the lost archive

  Radiation risks: Raiders of the lost archive Nature 485, 7397 (2012). http://www.nature.com/doifinder/10.1038/485162a Author: Alison Abbott Old collections of irradiated tissues could answer modern-day questions about the dangers of more

• Trial tests Austrian integrity body

  Trial tests Austrian integrity body Nature 485, 7396 (2012). http://www.nature.com/doifinder/10.1038/485015a Author: Alison Abbott Unfair-dismissal suit will show whether the young agency’s rulings are taken seriously. more

Market studies Abbott

• Global Continuous Glucose Monitoring Device Market 2011-2015

  TechNavio’s analysts forecast the the Global Continuous Glucose Monitoring Device market to grow at a CAGR of 11.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is worldwide rise in diabetic population. The Global Continuous Glucose Monitoring Device ma more

• Drug-eluting Stent Market in Japan 2011-2015

  TechNavio’s analysts forecast the DES market in Japan to grow at a CAGR of 10.2 over the period 2011–2015. One of the key factors contributing to this market growth is the lower rate of restenosis by DES. The DES market in Japan has also been witnessing the trend of increase in strategic alliances a more

• Global Prefilled Syringes Market 2010-2014

  TechNavio’s analysts forecast the Global Prefilled Syringes market to grow at a CAGR of 9 percent over the period 2010–2014. One of the key factors contributing to this market growth is the significant growth of pen injectors. The Global Prefilled Syringes market has also been witnessing an increase more

Websites Abbott